Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

New application for long-established local anesthetic

Aug. 1, 1997

Esteve describes glutamate release inhibitors

Aug. 1, 1997

University of Minnesota researchers report kappa-receptor ligands

Aug. 1, 1997

Potent calpain inhibitor discovered at Senju

July 31, 1997

Agents for Parkinson's disease prepared at Rhone-Poulenc Rorer

July 31, 1997

Potent and selective AMPA antagonist discovered by Yamanouchi

July 30, 1997

Nasal vs. rectal midazolam as premedication in children

July 30, 1997

D-Pharm reports results from toxicity study for neuroprotective compound

July 29, 1997

Talsaclidine: favorable preclinical and pharmacokinetic profile

July 29, 1997

Review of preclinical and clinical studies with xanomeline

July 29, 1997

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...